Cargando…
Impact of myo‐inositol trispyrophosphate (ITPP) on tumour oxygenation and response to irradiation in rodent tumour models
Tumour hypoxia is a well‐established factor of resistance in radiation therapy (RT). Myo‐inositol trispyrophosphate (ITPP) is an allosteric effector that reduces the oxygen‐binding affinity of haemoglobin and facilitates the release of oxygen by red blood cells. We investigated herein the oxygenatio...
Autores principales: | Tran, Ly‐Binh‐An, Cao‐Pham, Thanh‐Trang, Jordan, Bénédicte F., Deschoemaeker, Sofie, Heyerick, Arne, Gallez, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378184/ https://www.ncbi.nlm.nih.gov/pubmed/30575283 http://dx.doi.org/10.1111/jcmm.14092 |
Ejemplares similares
-
Treatment of hypoxia‐dependent cardiovascular diseases by myo‐inositol trispyrophosphate (ITPP)‐enhancement of oxygen delivery by red blood cells
por: Oknińska, Marta, et al.
Publicado: (2020) -
Oxygen therapeutic window induced by myo-inositol trispyrophosphate (ITPP)–Local pO(2) study in murine tumors
por: Krzykawska-Serda, Martyna, et al.
Publicado: (2023) -
Tumour angiogenesis normalized by myo‐inositol trispyrophosphate alleviates hypoxia in the microenvironment and promotes antitumor immune response
por: El Hafny‐Rahbi, Bouchra, et al.
Publicado: (2021) -
Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors
por: Schneider, Marcel A., et al.
Publicado: (2021) -
Combined endogenous MR biomarkers to assess changes in tumor oxygenation induced by an allosteric effector of hemoglobin
por: Cao‐Pham, Thanh‐Trang, et al.
Publicado: (2019)